Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 2
1989 4
1990 3
1991 1
1992 3
1993 3
1994 5
1995 3
1996 4
1997 2
1998 4
1999 4
2000 3
2001 4
2002 1
2003 3
2004 7
2005 5
2006 6
2007 4
2008 4
2009 3
2010 4
2011 4
2012 5
2013 3
2014 5
2015 13
2016 10
2017 15
2018 12
2019 13
2020 16
2021 9
2022 16
2023 12
2024 9
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

203 results

Results by year

Filters applied: . Clear all
Page 1
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.
Francque SM, Bedossa P, Ratziu V, Anstee QM, Bugianesi E, Sanyal AJ, Loomba R, Harrison SA, Balabanska R, Mateva L, Lanthier N, Alkhouri N, Moreno C, Schattenberg JM, Stefanova-Petrova D, Vonghia L, Rouzier R, Guillaume M, Hodge A, Romero-Gómez M, Huot-Marchand P, Baudin M, Richard MP, Abitbol JL, Broqua P, Junien JL, Abdelmalek MF; NATIVE Study Group. Francque SM, et al. N Engl J Med. 2021 Oct 21;385(17):1547-1558. doi: 10.1056/NEJMoa2036205. N Engl J Med. 2021. PMID: 34670042 Clinical Trial.
The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3.
McHugh CA, Chen CK, Chow A, Surka CF, Tran C, McDonel P, Pandya-Jones A, Blanco M, Burghard C, Moradian A, Sweredoski MJ, Shishkin AA, Su J, Lander ES, Hess S, Plath K, Guttman M. McHugh CA, et al. Nature. 2015 May 14;521(7551):232-6. doi: 10.1038/nature14443. Epub 2015 Apr 27. Nature. 2015. PMID: 25915022 Free PMC article.
Interaction between coat morphogenetic proteins SafA and SpoVID.
Costa T, Isidro AL, Moran CP Jr, Henriques AO. Costa T, et al. J Bacteriol. 2006 Nov;188(22):7731-41. doi: 10.1128/JB.00761-06. Epub 2006 Sep 1. J Bacteriol. 2006. PMID: 16950916 Free PMC article.
Here, we show that the interaction between SafA and SpoVID involves the PYYH motif (region B) but also a 13-amino-acid region (region A) just downstream of the N-terminal LysM domain of SafA. We show that deletion of region B does not block the interac …
Here, we show that the interaction between SafA and SpoVID involves the PYYH motif (region B) but also a 13-amino-acid region …
Outstanding questions in transplantation: B cells, alloantibodies, and humoral rejection.
Chong AS, Rothstein DM, Safa K, Riella LV. Chong AS, et al. Am J Transplant. 2019 Aug;19(8):2155-2163. doi: 10.1111/ajt.15323. Epub 2019 Apr 10. Am J Transplant. 2019. PMID: 30803121 Free PMC article. Review.
The cause of late graft loss has been under intense investigation, and chronic antibody-mediated rejection (AMR) has been identified as one of the leading causes, thus providing a strong rationale for basic science investigation into donor-specific B cells and antibodies i …
The cause of late graft loss has been under intense investigation, and chronic antibody-mediated rejection (AMR) has been identified as one …
Novel biologic therapies in relapsed or refractory diffuse large B cell lymphoma: CAR-T is not the only answer.
Paillassa J, Safa F. Paillassa J, et al. Leuk Res Rep. 2021 Dec 10;17:100282. doi: 10.1016/j.lrr.2021.100282. eCollection 2022. Leuk Res Rep. 2021. PMID: 35024331 Free PMC article. Review.
Patients with diffuse large B-cell lymphoma who have refractory or relapsed disease following first line treatment have a poor prognosis when treated with conventional therapies. ...
Patients with diffuse large B-cell lymphoma who have refractory or relapsed disease following first line treatment have a poor progno …
Diffuse Large B-cell Lymphoma of Testis: a Case Report and Current Literature Review.
Guler Y, Ucpinar B, Erbin A. Guler Y, et al. Folia Med (Plovdiv). 2020 Mar 31;62(1):200-203. doi: 10.3897/folmed.62.e47874. Folia Med (Plovdiv). 2020. PMID: 32337891 Review.
The vast majority of PTL are diffuse large B-cell lymphoma (DLBCL). CASE PRESENTATION: We present a case of PTL diagnosed in a 68-year-old male patient and also, we discuss the incidence, clinical presentation, prognostic factors and management of this rare pathology in th …
The vast majority of PTL are diffuse large B-cell lymphoma (DLBCL). CASE PRESENTATION: We present a case of PTL diagnosed in a 68-yea …
NOTCH Signaling in Mantle Cell Lymphoma: Biological and Clinical Implications.
Deshotels L, Safa FM, Saba NS. Deshotels L, et al. Int J Mol Sci. 2023 Jun 17;24(12):10280. doi: 10.3390/ijms241210280. Int J Mol Sci. 2023. PMID: 37373427 Free PMC article. Review.
Notably, NOTCH1 and NOTCH2 were found to be mutated in multiple B cell lymphomas, including 5-10% of MCL, with most of these mutations occurring within the PEST domain of the protein. The NOTCH genes play a critical role in the early and late phases of normal B cell …
Notably, NOTCH1 and NOTCH2 were found to be mutated in multiple B cell lymphomas, including 5-10% of MCL, with most of these mutation …
Profiling the activity of the para-caspase MALT1 in B-cell acute lymphoblastic leukemia for potential targeted therapeutic application.
Safa FM, Rasmussen T, Fontan L, Xia M, Melnick A, Wiestner A, Lobelle-Rich P, Burger JA, Mouawad Y, Safah H, Flemington EK, Saba NS. Safa FM, et al. Haematologica. 2024 May 1;109(5):1348-1358. doi: 10.3324/haematol.2023.283178. Haematologica. 2024. PMID: 37767562 Free PMC article.
B-cell acute lymphoblastic leukemia (B-ALL) remains a hard-to-treat disease with a poor prognosis in adults. ...In conclusion, our evidence suggests a novel role for MALT1 in B-ALL through Myc regulation and provides support for clinical testing of MALT1 inhi …
B-cell acute lymphoblastic leukemia (B-ALL) remains a hard-to-treat disease with a poor prognosis in adults. ...In conclusion, …
MicroRNAs in breast cancer: Roles, functions, and mechanism of actions.
Abolghasemi M, Tehrani SS, Yousefi T, Karimian A, Mahmoodpoor A, Ghamari A, Jadidi-Niaragh F, Yousefi M, Kafil HS, Bastami M, Edalati M, Eyvazi S, Naghizadeh M, Targhazeh N, Yousefi B, Safa A, Majidinia M, Rameshknia V. Abolghasemi M, et al. J Cell Physiol. 2020 Jun;235(6):5008-5029. doi: 10.1002/jcp.29396. Epub 2019 Nov 14. J Cell Physiol. 2020. PMID: 31724738 Review.
Herein, we will review the roles of these RNA molecules in several important signaling pathways, such as transforming growth factor, Wnt, Notch, nuclear factor-kappa B, phosphoinositide-3-kinase/Akt, and extracellular-signal-regulated kinase/mitogen activated protein kinas …
Herein, we will review the roles of these RNA molecules in several important signaling pathways, such as transforming growth factor, Wnt, No …
203 results